CG Oncology (CGON) Change in Receivables (2024 - 2026)
CG Oncology posted quarterly Change in Receivables of $587000.0 for Q1 2026, up 234.63% year-on-year from $175416.0 in Q1 2025, and up 95.02% on a QoQ basis from $301000.0 in Q4 2025.
CG Oncology (CGON) has 3 years of Change in Receivables data on file, last reported at $587000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables rose 234.63% year-over-year to $587000.0; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (changed N/A YoY), and the FY2025 full-year result was $320000.0, down 53.56% from the prior year.
- Change in Receivables for Q1 2026 stood at $587000.0, up from $301000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $644000.0 in Q4 2024 and bottomed at -$436000.0 in Q1 2025.
- The 3-year median for Change in Receivables is $238000.0 (2025), against an average of $215142.9.
- Peak annual rise in Change in Receivables reached 628.89% in 2025, while the deepest fall reached 53.26% in 2025.
- A 3-year view of Change in Receivables shows it stood at $644000.0 in 2024, then tumbled by 53.26% to $301000.0 in 2025, then surged by 95.02% to $587000.0 in 2026.
- The last three Change in Receivables figures came in at $587000.0 (Q1 2026), $301000.0 (Q4 2025), and $238000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 110.42 Mn |
| 10 | CG Oncology | 5.01 Bn | 5.01 Bn | -1.88 Mn | 587,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 587,000.00 |
| Mar 31, 2026 | 587,000.00 |
| Dec 31, 2025 | 301,000.00 |
| Dec 31, 2025 | 301,000.00 |
| Sep 30, 2025 | 238,000.00 |
| Sep 30, 2025 | 238,000.00 |
| Jun 30, 2025 | 217,000.00 |
| Jun 30, 2025 | 217,000.00 |
| Mar 31, 2025 | -436,000.00 |
| Mar 31, 2025 | -436,000.00 |
| Dec 31, 2024 | 644,000.00 |
| Dec 31, 2024 | 644,000.00 |
| Sep 30, 2024 | -45,000.00 |
| Sep 30, 2024 | -45,000.00 |